Impaact4tb - The Aurum Institute

Press Statement: Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

The Aurum Institute and its partners also announce the launch of the next phase of work to improve access to shorter TB prevention treatments for children and pregnant women Johannesburg, 3 Aug...
Hope for TB patients as treatment cost cut by more than half

...
Aurum showcases expertise at SA TB Conference

SA TB Conference delegates packed the hall for an Aurum satellite session on: Scaling up shorter TB preventive treatment (TPT) - is there a role for new TB infection tests in South Africa? Prof Viol...
Rollout of new drug resistant TB treatment expected next year

...
The NIH/DAIDS Cross-Network TB Vaccine Working Group calls for people living with HIV to be included in tuberculosis vaccine development

...
Aurum at the 53rd Union World Conference on Lung Health

The Aurum Institute will join colleagues, partners, advocates and friends at the biggest scientific conference on lung health, The Union World Conference on Lung Health which will take place virtually...
250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries

Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based pre...
World TB Day 2023: Aurum Ghana donates commodities to health facilities

On 24 March 2023, Ghana joined the rest of the world in observing World TB Day, a day set aside to increase public awareness of TB, highlight the suffering that the disease continues to cause, and ins...
Community care model improves uptake of TB preventive therapy, KZN study finds

...
War against TB heightened as efforts to expand access to shorter TB prevention advances elimination

...
Aurum showcases HIV and TB expertise at INTEREST 2023

Fundação Aurum, together with The Aurum Institute South Africa, participated in the INTEREST 2023 conference, showcasing the innovative work the Aurum Group does in HIV research, treatment, and care...

Press Statement: Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

Hope for TB patients as treatment cost cut by more than half

Aurum showcases expertise at SA TB Conference

Rollout of new drug resistant TB treatment expected next year

The NIH/DAIDS Cross-Network TB Vaccine Working Group calls for people living with HIV to be included in tuberculosis vaccine development

Aurum at the 53rd Union World Conference on Lung Health

250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries

World TB Day 2023: Aurum Ghana donates commodities to health facilities

Community care model improves uptake of TB preventive therapy, KZN study finds

War against TB heightened as efforts to expand access to shorter TB prevention advances elimination

Aurum showcases HIV and TB expertise at INTEREST 2023

Popular Tags

Most Read

Recent Posts

About Us

What We do

Aurum Global

Head Office